• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经纤维瘤病 1 以 TSC/Rheb 非依赖性方式调节 mTOR 介导的星形胶质细胞生长和神经胶质瘤形成。

Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.

机构信息

Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15996-6001. doi: 10.1073/pnas.1019012108. Epub 2011 Sep 6.

DOI:10.1073/pnas.1019012108
PMID:21896734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3179115/
Abstract

Converging evidence from the analysis of human brain tumors and genetically engineered mice has revealed that the mammalian target of rapamycin (mTOR) pathway is a central regulator of glial and glioma cell growth. In this regard, mutational inactivation of neurofibromatosis-1 (NF1), tuberous sclerosis complex (TSC), and PTEN genes is associated with glioma formation, such that pharmacologic inhibition of mTOR signaling results in attenuated tumor growth. This shared dependence on mTOR suggests that PTEN and NF1 (neurofibromin) glial growth regulation requires TSC/Rheb (Ras homolog enriched in brain) control of mTOR function. In this report, we use a combination of genetic silencing in vitro and conditional mouse transgenesis approaches in vivo to demonstrate that neurofibromin regulates astrocyte cell growth and glioma formation in a TSC/Rheb-independent fashion. First, we show that Nf1 or Pten inactivation, but not Tsc1 loss or Rheb overexpression, increases astrocyte cell growth in vitro. Second, Nf1-deficient increased mTOR signaling and astrocyte hyperproliferation is unaffected by Rheb shRNA silencing. Third, conditional Tsc1 inactivation or Rheb overexpression in glial progenitors of Nf1(+/-) mice does not lead to glioma formation. Collectively, these findings establish TSC/Rheb-independent mechanisms for mTOR-dependent glial cell growth control and gliomagenesis relevant to the design of therapies for individuals with glioma.

摘要

来自人类脑瘤分析和基因工程小鼠的汇聚证据表明,哺乳动物雷帕霉素靶蛋白(mTOR)途径是神经胶质细胞和神经胶质瘤细胞生长的中央调节剂。在这方面,神经纤维瘤病 1(NF1)、结节性硬化症复合物(TSC)和 PTEN 基因的突变失活与神经胶质瘤的形成有关,因此,mTOR 信号的药理学抑制导致肿瘤生长减弱。这种对 mTOR 的共同依赖性表明,PTEN 和 NF1(神经纤维瘤蛋白)对神经胶质生长的调节需要 TSC/Rheb(富含大脑的 Ras 同源物)控制 mTOR 功能。在本报告中,我们使用体外基因沉默和体内条件性转基因方法相结合,证明神经纤维瘤蛋白以 TSC/Rheb 独立的方式调节星形胶质细胞的生长和神经胶质瘤的形成。首先,我们表明,Nf1 或 Pten 的失活,但不是 Tsc1 的缺失或 Rheb 的过表达,会增加体外星形胶质细胞的生长。其次,Nf1 缺陷增加 mTOR 信号和星形胶质细胞过度增殖不受 Rheb shRNA 沉默的影响。第三,条件性 Tsc1 失活或 Rheb 过表达在 Nf1(+/-)小鼠的神经胶质前体细胞中不会导致神经胶质瘤的形成。总之,这些发现确立了 TSC/Rheb 独立的 mTOR 依赖性神经胶质细胞生长控制机制和神经胶质瘤发生,这与为神经胶质瘤患者设计治疗方法有关。

相似文献

1
Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.神经纤维瘤病 1 以 TSC/Rheb 非依赖性方式调节 mTOR 介导的星形胶质细胞生长和神经胶质瘤形成。
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15996-6001. doi: 10.1073/pnas.1019012108. Epub 2011 Sep 6.
2
Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis.结节性硬化症复合物-Rheb 信号轴的非经典功能。
EMBO Mol Med. 2011 Apr;3(4):189-200. doi: 10.1002/emmm.201100131. Epub 2011 Mar 16.
3
Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation.结节性硬化复合物1(Tsc1)表达缺失导致Rheb/S6K信号通路增强,这对星形胶质细胞大小调节很重要。
Glia. 2004 Aug 1;47(2):180-8. doi: 10.1002/glia.20036.
4
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.结节性硬化症复合基因产物,即结节蛋白和错构瘤蛋白,通过作为Rheb的GTP酶激活蛋白复合物来控制mTOR信号传导。
Curr Biol. 2003 Aug 5;13(15):1259-68. doi: 10.1016/s0960-9822(03)00506-2.
5
Phospholipase D1 is an effector of Rheb in the mTOR pathway.磷脂酶D1是mTOR通路中Rheb的效应器。
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8286-91. doi: 10.1073/pnas.0712268105. Epub 2008 Jun 11.
6
Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway.氧化还原通过调节 TSC1/TSC2-Rheb GTP 酶途径来调节哺乳动物雷帕霉素靶蛋白复合物 1(mTORC1)的活性。
J Biol Chem. 2011 Sep 16;286(37):32651-60. doi: 10.1074/jbc.M111.238014. Epub 2011 Jul 22.
7
Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.Akt或MEK介导的mTOR抑制可抑制Nf1视神经胶质瘤的生长。
Neuro Oncol. 2015 Jun;17(6):843-53. doi: 10.1093/neuonc/nou329. Epub 2014 Dec 21.
8
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.1型神经纤维瘤病(Nf1)杂合的脑小胶质细胞分泌旁分泌因子,促进Nf1缺陷型星形胶质细胞和胶质瘤生长。
Hum Mol Genet. 2007 May 1;16(9):1098-112. doi: 10.1093/hmg/ddm059. Epub 2007 Mar 30.
9
Farnesyltransferase inhibitors reverse altered growth and distribution of actin filaments in Tsc-deficient cells via inhibition of both rapamycin-sensitive and -insensitive pathways.法尼基转移酶抑制剂通过抑制雷帕霉素敏感和不敏感途径,逆转结节性硬化症缺陷细胞中肌动蛋白丝的生长和分布改变。
Mol Cancer Ther. 2005 Jun;4(6):918-26. doi: 10.1158/1535-7163.MCT-04-0347.
10
PDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascade.丙酮酸脱氢酶激酶4(PDK4)蛋白通过激活环磷酸腺苷反应元件结合蛋白(CREB)-富含脑的Ras同源物(RHEB)-哺乳动物雷帕霉素靶蛋白复合体1(mTORC1)信号级联反应来促进肿瘤发生。
J Biol Chem. 2014 Oct 24;289(43):29739-49. doi: 10.1074/jbc.M114.584821. Epub 2014 Aug 27.

引用本文的文献

1
Molecular-targeted therapy for childhood low-grade glial and glioneuronal tumors.儿童低级别神经胶质瘤和神经胶质神经元肿瘤的分子靶向治疗。
Childs Nerv Syst. 2024 Oct;40(10):3251-3262. doi: 10.1007/s00381-024-06486-6. Epub 2024 Jun 15.
2
An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.神经纤维瘤病 1 型伴视神经通路胶质瘤概述:发病机制、危险因素和治疗策略。
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):8. doi: 10.1167/iovs.65.6.8.
3
Visual Deficits and Diagnostic and Therapeutic Strategies for Neurofibromatosis Type 1: Bridging Science and Patient-Centered Care.1型神经纤维瘤病的视觉缺陷及诊断与治疗策略:连接科学与以患者为中心的医疗
Vision (Basel). 2024 May 9;8(2):31. doi: 10.3390/vision8020031.
4
Pediatric low-grade glioma models: advances and ongoing challenges.小儿低度胶质瘤模型:进展与持续挑战
Front Oncol. 2024 Jan 22;13:1346949. doi: 10.3389/fonc.2023.1346949. eCollection 2023.
5
Pten knockout affects drug resistance differently in melanoma and kidney cancer.PTEN 敲除对黑色素瘤和肾癌的耐药性有不同的影响。
Pharmacol Rep. 2023 Oct;75(5):1187-1199. doi: 10.1007/s43440-023-00523-y. Epub 2023 Sep 6.
6
Identification of ligand-receptor pairs that drive human astrocyte development.鉴定驱动人类星形胶质细胞发育的配体-受体对。
Nat Neurosci. 2023 Aug;26(8):1339-1351. doi: 10.1038/s41593-023-01375-8. Epub 2023 Jul 17.
7
Metabolic Rewiring in Adult-Type Diffuse Gliomas.成人型弥漫性神经胶质瘤中的代谢重编程。
Int J Mol Sci. 2023 Apr 16;24(8):7348. doi: 10.3390/ijms24087348.
8
RAS and beyond: the many faces of the neurofibromatosis type 1 protein.RAS 及其他:神经纤维瘤病 1 型蛋白的多面性。
Dis Model Mech. 2022 Feb 1;15(2). doi: 10.1242/dmm.049362. Epub 2022 Feb 21.
9
Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.鉴定发育中大脑中的 FMRP 靶 mRNA:FMRP 可能在皮质发生过程中协调 Ras/MAPK、Wnt/β-catenin 和 mTOR 信号通路。
Mol Brain. 2020 Dec 16;13(1):167. doi: 10.1186/s13041-020-00706-1.
10
Clinical trials using molecular stratification of pediatric brain tumors.使用小儿脑肿瘤分子分层的临床试验。
Transl Pediatr. 2020 Apr;9(2):144-156. doi: 10.21037/tp.2020.03.04.

本文引用的文献

1
Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.神经纤维瘤病-1 以脑区特异性方式调节神经胶质祖细胞的增殖和胶质分化。
Genes Dev. 2010 Oct 15;24(20):2317-29. doi: 10.1101/gad.1957110. Epub 2010 Sep 28.
2
Cyclic AMP controls mTOR through regulation of the dynamic interaction between Rheb and phosphodiesterase 4D.环腺苷酸通过调节 Rheb 和磷酸二酯酶 4D 之间的动态相互作用来控制 mTOR。
Mol Cell Biol. 2010 Nov;30(22):5406-20. doi: 10.1128/MCB.00217-10. Epub 2010 Sep 13.
3
The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo.神经纤维瘤病 1 型肿瘤抑制因子通过调节体外和体内信号转导子和转录激活子 3 的活性来控制细胞生长。
Cancer Res. 2010 Feb 15;70(4):1356-66. doi: 10.1158/0008-5472.CAN-09-2178. Epub 2010 Feb 2.
4
Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains.Pdk1和Pten基因缺陷型大脑中PI3K信号传导的细胞类型特异性
Genes Dev. 2009 Jul 15;23(14):1619-24. doi: 10.1101/gad.1799609.
5
DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.DEPTOR是一种mTOR抑制剂,在多发性骨髓瘤细胞中经常过度表达,是其生存所必需的。
Cell. 2009 May 29;137(5):873-86. doi: 10.1016/j.cell.2009.03.046. Epub 2009 May 14.
6
The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord.Rheb-mTOR信号通路在脊髓损伤后反应性星形胶质细胞中上调。
J Neurosci. 2009 Jan 28;29(4):1093-104. doi: 10.1523/JNEUROSCI.4103-08.2009.
7
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.全面的基因组特征分析确定了人类胶质母细胞瘤的基因和核心通路。
Nature. 2008 Oct 23;455(7216):1061-8. doi: 10.1038/nature07385. Epub 2008 Sep 4.
8
Phospholipase D1 is an effector of Rheb in the mTOR pathway.磷脂酶D1是mTOR通路中Rheb的效应器。
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8286-91. doi: 10.1073/pnas.0712268105. Epub 2008 Jun 11.
9
Generation of a reporter mouse line expressing Akt and EGFP upon Cre-mediated recombination.通过Cre介导的重组产生在重组时表达Akt和增强绿色荧光蛋白(EGFP)的报告基因小鼠品系。
Genesis. 2008 May;46(5):256-64. doi: 10.1002/dvg.20388.
10
Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.1型神经纤维瘤病视神经胶质瘤小鼠模型中的临床前癌症治疗
Cancer Res. 2008 Mar 1;68(5):1520-8. doi: 10.1158/0008-5472.CAN-07-5916.